Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07531433) titled 'Post-Trial Access to ATH434 for Patients With Multiple System Atrophy' on April 9.
Study Type: Expanded Access
Primary Sponsor: Alterity Therapeutics
Condition:
Multiple System Atrophy
Intervention:
Drug: ATH434
Recruitment Status: Not recruiting
Date of First Enrollment: January 1, 2022
To know more, visit https://clinicaltrials.gov/study/NCT07531433
Disclaimer: Curated by HT Syndication....